Hopkins researchers recommend reclassifying psilocybin, the drug in ‘magic’ mushrooms, from schedule I to schedule IV – The Hub at Johns Hopkins

Hopkins researchers recommend reclassifying psilocybin, the drug in ‘magic’ mushrooms, from schedule I to schedule IV  The Hub at Johns Hopkins

In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical …